Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant thymidine phosphorylase encapsulated with autologous erythrocytes |
---|---|
Date Designated: | 12/13/2010 |
Orphan Designation: | Treatment of mitochondrial neurogastrointestinal encephalomyopathydue to thymidine phosphorylase deficiency. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
St. George's University of London Joint Research Office London United Kingdom The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-